VACCINEX, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

VACCINEX, INC. reported Cash And Cash Equivalents At Carrying Value of $1.11 million for the year ending 2024.

  • VACCINEX, INC. showed a decrease of -27.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from VACCINEX, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2016 to 2024), VACCINEX, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 33.4%.
  • Historical annual values: Fiscal year 2024: $1.11 million | Fiscal year 2023: $1.54 million | Fiscal year 2022: $6.39 million | Fiscal year 2021: $8.59 million | Fiscal year 2020: $10.60 million | Fiscal year 2019: $2.78 million | Fiscal year 2018: $5.62 million | Fiscal year 2017: $4.18 million | Fiscal year 2016: $1.66 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: